- Hong Kong small and mid-cap stocks are reshaping their market layouts through strategic acquisitions and operational adjustments across various sectors.
- Angelalign led a 120 million HKD investment in digital orthodontics to accelerate industry consolidation, while Jacobson Pharma acquired a 19% stake in Beijing XINLEJIA to expand production capacity.
- China Travel HK acquired a core commercial property in Wan Chai for 898 million HKD to bet on tourism recovery, alongside strategic maneuvers and share buybacks by other firms.